NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class (Descending) | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
00703-4766-81 | 00703-4766 | Paclitaxel | Paclitaxel | 6.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | March 3, 2016 | Aug. 31, 2019 | No Longer Used |
00703-4767-01 | 00703-4767 | Paclitaxel | Paclitaxel | 6.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Oct. 23, 2008 | Aug. 31, 2020 | No Longer Used |
00703-5720-01 | 00703-5720 | Docetaxel | Docetaxel | 20.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Dec. 31, 2015 | Nov. 30, 2018 | No Longer Used |
00703-5730-01 | 00703-5730 | Docetaxel | Docetaxel | 80.0 mg/4mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Dec. 31, 2015 | Nov. 30, 2018 | No Longer Used |
16714-0465-01 | 16714-0465 | Docetaxel | Docetaxel | 20.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Jan. 1, 2016 | Nov. 30, 2018 | No Longer Used |
16714-0500-01 | 16714-0500 | Docetaxel | Docetaxel | 80.0 mg/4mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Jan. 1, 2016 | Nov. 30, 2018 | No Longer Used |
16729-0120-49 | 16729-0120 | Docetaxel | Docetaxel | Chemotherapy | Antimitotic Agent | Taxane | June 30, 2011 | June 18, 2018 | No Longer Used | ||
16729-0228-50 | 16729-0228 | Docetaxel | Docetaxel | Chemotherapy | Antimitotic Agent | Taxane | June 30, 2011 | June 18, 2018 | No Longer Used | ||
25021-0213-05 | 25021-0213 | Paclitaxel | Paclitaxel | 6.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Sept. 27, 2011 | Oct. 31, 2016 | No Longer Used |
25021-0213-17 | 25021-0213 | Paclitaxel | Paclitaxel | 6.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Sept. 27, 2011 | Oct. 31, 2016 | No Longer Used |
Found 10,000 results in 3 milliseconds — Export these results